Mi Ni Huang

16.6k total citations · 1 hit paper
11 papers, 699 citations indexed

About

Mi Ni Huang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Mi Ni Huang has authored 11 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Mi Ni Huang's work include Cancer Genomics and Diagnostics (3 papers), Genetic factors in colorectal cancer (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Mi Ni Huang is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Genetic factors in colorectal cancer (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Mi Ni Huang collaborates with scholars based in China, Singapore and United States. Mi Ni Huang's co-authors include Steve Rozen, Bin Tean Teh, Patrick Tan, Arnoud Boot, Alvin Wei Tian Ng, Jing Quan Lim, John R. McPherson, Willie Yu, Song Ling Poon and Mark Barnes and has published in prestigious journals such as PLoS ONE, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Mi Ni Huang

9 papers receiving 693 citations

Hit Papers

Aristolochic acids and their derivatives are widely impli... 2017 2026 2020 2023 2017 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi Ni Huang China 7 305 249 172 150 149 11 699
Arnoud Boot Netherlands 15 277 0.9× 384 1.5× 143 0.8× 161 1.1× 106 0.7× 35 906
Cedric Chuan Young Ng Singapore 15 207 0.7× 317 1.3× 140 0.8× 174 1.2× 197 1.3× 47 933
R Serreyn Belgium 17 137 0.4× 148 0.6× 130 0.8× 267 1.8× 194 1.3× 32 861
Jie Meng China 15 158 0.5× 258 1.0× 55 0.3× 124 0.8× 87 0.6× 52 561
Mohan C. Pant India 20 144 0.5× 539 2.2× 53 0.3× 212 1.4× 66 0.4× 40 933
Natasha P. Clayton United States 13 82 0.3× 158 0.6× 43 0.3× 69 0.5× 42 0.3× 29 510
Angela Howes United Kingdom 15 180 0.6× 272 1.1× 37 0.2× 333 2.2× 154 1.0× 35 783
Rohit Upadhyay India 18 169 0.6× 447 1.8× 20 0.1× 146 1.0× 53 0.4× 49 743
Jiyuan Yang China 11 188 0.6× 294 1.2× 49 0.3× 124 0.8× 50 0.3× 26 477
Adam W. Grasso United States 5 138 0.5× 261 1.0× 138 0.8× 119 0.8× 33 0.2× 6 883

Countries citing papers authored by Mi Ni Huang

Since Specialization
Citations

This map shows the geographic impact of Mi Ni Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Ni Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Ni Huang more than expected).

Fields of papers citing papers by Mi Ni Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Ni Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Ni Huang. The network helps show where Mi Ni Huang may publish in the future.

Co-authorship network of co-authors of Mi Ni Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Ni Huang. A scholar is included among the top collaborators of Mi Ni Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Ni Huang. Mi Ni Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Chang, Tiancheng Xie, Mi Ni Huang, et al.. (2025). Natural compound rhein-based bimetallic nanosheets to induce ferroptosis and activate STING pathway for enhanced cancer immunotherapy. Chemical Engineering Journal. 526. 171051–171051.
2.
Huang, Mi Ni, Duanzhuo Li, Shengjie Liao, et al.. (2025). Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells. PLoS ONE. 20(5). e0322746–e0322746. 1 indexed citations
3.
Jiang, P. Z., Baoxin Chen, Mi Ni Huang, et al.. (2025). PGC1A Restores Mitochondrial Health to Attenuate EMT During Lens Epithelial Fibrosis via Regulating TFAM. Investigative Ophthalmology & Visual Science. 66(12). 67–67. 1 indexed citations
4.
Sun, Yan, Xiaoran Wang, Jiani Wang, et al.. (2022). Long Non-Coding RNA H19 Prevents Lens Fibrosis through Maintaining Lens Epithelial Cell Phenotypes. Cells. 11(16). 2559–2559. 10 indexed citations
6.
Bergstrom, Erik N., Mi Ni Huang, Mark Barnes, et al.. (2019). SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genomics. 20(1). 685–685. 132 indexed citations
7.
Boot, Arnoud, Mi Ni Huang, Alvin Wei Tian Ng, et al.. (2018). In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. Genome Research. 28(5). 654–665. 91 indexed citations
8.
Ng, Alvin Wei Tian, Song Ling Poon, Mi Ni Huang, et al.. (2017). Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Science Translational Medicine. 9(412). 279 indexed citations breakdown →
9.
Huang, Mi Ni, John R. McPherson, Ioana Cutcutache, et al.. (2015). MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations. Scientific Reports. 5(1). 13321–13321. 99 indexed citations
10.
Poon, Song Ling, Mi Ni Huang, John R. McPherson, et al.. (2015). Mutation signatures implicate aristolochic acid in bladder cancer development. Genome Medicine. 7(1). 38–38. 76 indexed citations
11.
Zhou, Jianfeng, Qinglei Gao, Xiaoyuan Huang, et al.. (2006). Oncolytic adenovirus-mediated transfer of the antisense chk2 selectively inhibits tumor growth in vitro and in vivo. Cancer Gene Therapy. 13(10). 930–939. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026